Ducommun's stock surged 5.02% during intraday trading on Wednesday, following a series of positive analyst actions.
The rally was driven by multiple Wall Street firms raising their price targets on the company. RBC Capital increased its target to $155 from $150 while maintaining an Outperform rating. Separately, B. Riley lifted its target more significantly to $187 from $155 and reaffirmed a Buy rating on the shares.
These upward revisions reflect growing analyst confidence in Ducommun's prospects, which appears to have spurred investor buying activity during the session.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments